Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

3.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.2K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

457
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
457
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

310
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
310
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

534
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
534
Transcription Elongation Factors02:35

Transcription Elongation Factors

13.5K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.5K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategic modulation to avoid radiation toxicities for brain integrity (SMART-BRAIN).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Genome reorganization and its functional impact during breast cancer progression.

eLife·2026
Same author

RNA Binding Protein PCBP1 Functions in the Endothelial-to-Hematopoietic Transition During Hematopoietic Stem Cell Formation.

Experimental hematology·2026
Same author

Individual, community, and structural determinants of diagnostic testing decisions during public health crises: evidence from dynamic access and behavioural trade-offs.

BMJ public health·2026
Same author

Update of germ line RUNX1 variant curation rules: version 3.1.

Blood advances·2026
Same author

Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarks.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 23, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.5K

The core-binding factor beta subunit is required for bone formation and hematopoietic maturation.

Janelle Miller1, Alan Horner, Terryl Stacy

  • 1Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.

Nature Genetics
|November 16, 2002
PubMed
Summary

Core-binding factor beta (Cbfbeta) is essential for hematopoietic stem cell emergence and skeletal development. Restoring Cbfbeta function rescues fetal liver hematopoiesis but leads to skeletal defects and impaired blood cell differentiation.

More Related Videos

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

8.1K
Homing of Hematopoietic Cells to the Bone Marrow
10:40

Homing of Hematopoietic Cells to the Bone Marrow

Published on: March 17, 2009

30.0K

Related Experiment Videos

Last Updated: Jan 23, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.5K
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

8.1K
Homing of Hematopoietic Cells to the Bone Marrow
10:40

Homing of Hematopoietic Cells to the Bone Marrow

Published on: March 17, 2009

30.0K

Area of Science:

  • Developmental biology
  • Hematopoiesis
  • Skeletal biology

Background:

  • Core-binding factor beta (Cbfbeta) is a crucial non-DNA-binding subunit of Cbf transcription factors.
  • Cbfbeta deficiency in mice results in a critical blockage of fetal liver hematopoiesis during hematopoietic stem cell (HSC) emergence.

Purpose of the Study:

  • To investigate the role of Cbfbeta in fetal liver hematopoiesis and skeletal development.
  • To determine if restoring Cbfbeta function in specific cell types can rescue developmental defects in Cbfbeta-deficient embryos.

Main Methods:

  • Genetic manipulation to provide Cbfbeta function in endothelial cells and hematopoietic progenitors of Cbfbeta-deficient embryos.
  • Analysis of fetal liver hematopoiesis at various embryonic stages (E12.5, E17.5).
  • Assessment of skeletal development and ossification in rescued mice.

Main Results:

  • Restoration of Cbfbeta function rescued fetal liver hematopoiesis in Cbfbeta-deficient embryos.
  • Rescued mice exhibited severe skeletal development defects and died at birth.
  • While hematopoiesis was restored by embryonic day 12.5, significant impairments in lymphopoiesis and myelopoiesis were observed by embryonic day 17.5.

Conclusions:

  • Cbfbeta is indispensable for HSC emergence, proper bone formation, and the normal differentiation of lymphoid and myeloid cells.
  • The study highlights the multifaceted role of Cbfbeta in both hematopoiesis and skeletal development.